- £174.33m
- £187.11m
- £0.51m
REG-4basebio Plc: 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
AnnouncementREG-4basebio Plc: 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
AnnouncementREG-4basebio Plc: 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
AnnouncementREG-4basebio Plc: Directors' Dealings
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Exercise of Options
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 09/02/2024
AnnouncementREG - AIM - AIM Notice - 07/02/2024
AnnouncementREG-4basebio Plc: Exercise of Options
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
AnnouncementREG-4basebio Plc: Holding(s) in Company
Announcement